Back ground: Nifedipine is a calcium channel blocker and is used in treatment of angina of angina pectoris and hypertension. Nifedipine readily and almost completely absorbed from GIT, but undergoes first pass metabolism, resulting in low oral bioavailability is about 50%.
INTRODUCTION
Microencapsulation is one of the newly developed techniques. Microencapsulation for oral use has been employed to sustain the drug release, and to reduce or eliminate gastrointestinal tract irritation. In addition, multiparticulate delivery systems spread out more uniformly in the gastrointestinal tract. This results in more reproducible drug absorption and reduces local irritation when compared to single-unit dosage forms such as no disintegrating, polymeric matrix tablets. Unwanted intestinal retention of the polymeric material, which may occur with matrix tablets on chronic dosing, can also be avoided. Microencapsulation is used to modify and retard drug release. Due to its small particle size, are widely distributed throughout the gastrointestinal tract which improves drug absorption and reduces side effects due to localized build-up of irritating drugs against the gastrointestinal mucosa 1 .
Microencapsulation is a process of incorporating drugs into small size multi particulate units. As a process it is a means of applying relatively thin coatings to small particles of solids or droplets of liquids. Microencapsulation developed for use in medicine consists of solid or liquid core material containing one or more drugs enclosed in coating material 2 . The core may also be referred as nucleus and the coating as wall or sheet. In the present study microencapsulation was selected as a method to design sustained release dosage forms because it is a rapidly expanding technology. In this method relatively thin coatings are applied to small particles of solids or droplets of liquids and dispersions. Microencapsulation also used in converting liquids to solids, altering colloidal and surface properties, providing ISSN: 2250-1177
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Nifedipine is a calcium channel blocker available in yellow, crystalline powder, thermostable and non-hygroscopic in nature. It is insoluble in water, freely soluble in acetone and sparingly soluble in ethanol 3, 4 . The bioavailability of nifedipine is 50% and it binds with plasma to about 96%. Its half-life is 2-3hrs and effective concentration is about 15ng/ml. Nifedipine readily and almost completely absorbed from GIT, but undergoes first pass metabolism. The volume of distribution after oral administration was found to be 1.32L/kg 5 . Nifedipine is used in treatment and prophylaxis of angina of angina pectoris, Reynaud's syndrome and hypertension. Therefore, preparation of a sustained release formulation may be desirable. 
MATERIALS AND METHODS

Materials
Methods
Pre-formulation studies
Organoleptic properties
The organoleptic character of the drug like color, odor and appearance play an important role in the identification of the sample, and hence they should be recorded in a descriptive terminology.
Solubility studies
It is important to know about solubility characteristics of a drug in aqueous systems, since they must possess some limited aqueous solubility to elicit a therapeutic response. Solubility was carried out in water, 0.1N HCl, 0.1N NaOH, 6.8 pH phosphate buffer, 7.4 pH phosphate buffer.
Determination of melting point
Melting point of the drug was determined by capillary tube method. Take a small amount of the drug in a capillary tube closed at one end and was placed in Thieles melting point apparatus and the temperature at which the drug melts were noted. Average of triplicate readings was taken.
Determination of absorption maxima values (λmax)
Standard stock solution of drug (100μg/ml) was prepared in 7.4 pH phosphate buffer. For the selection of analytical wavelength, solution of nifedipine of concentration 30μg/ml was prepared by appropriate dilution of standard stock solution with phosphate buffer pH 7.4 and scanned in the spectrum range from 200 to 400nm. From this overlain spectrum of the drug, the wavelength with maximum absorbance was chosen for further analysis.
Construction of standard calibration curve of nifedipine:
Preparation of standard calibration curve of nifedipine in 7.4 pH phosphate buffer Procedure:
Preparation of standard solution 1 st Stock: 1000µg/ml solution of nifedipine was prepared by dissolving 100 mg of nifedipine in 10ml methanol and the volume was made up to 100ml with 7.4 pH phosphate buffer. The above second stock solution was serially diluted with 7.4 pH phosphate buffer to get the final concentrations of 10, 20, 30, 40, 50 and 60µg/ml. The absorbance of each concentration was measured 254nm using UV-Visible spectrophotometer and graph was plotted against the concentration and absorbance 6 .
Drug and excipients compatibility study
To investigate any possible interactions between the drug and excipients used, the FT-IR spectra of pure nifedipine and its physical mixture with ethyl cellulose and hydroxylpropyl methylcellulose were carried out using Bomem FT-IR MB-II spectrophotometer. The samples were prepared as KBr (potassium bromide) disks compressed under a pressure of 10 Ton/nm 2 . The wave number selected ranged between 400 and 4800cm -1 .
Preparation of nifedipine microspheres
Emulsification (o/w) solvent evaporation method was employed in the preparation of nifedipine microparticles using ethyl cellulose and combination of ethylcellulose and hydroxylpropylmethylcellulose as the polymers. Polymer was dissolved in 10ml of dichloromethane. To this 45mg of drug was added and mixed thoroughly. The above organic phase was added drop wise to 100ml of 1% PVA solution under magnetic stirrer at 800 rpm by keeping at 40 0 C and stirring is continued until total evaporation of dichloromethane 7, 8 . Then the solution was filtered and product was dried. Different formulations were prepared by taking different drug to polymer ratios 1:0.5, 1:1, 1:1.5, 1:2, 1:2.5, 1:3, 1:3.5 and 1:4 and 1:1, 1:2, 1:3 and 1:4 of ethylcellulose and combination of equal ratios of ethylcellulose and hydroxylpropylmethylcellulose respectively. The prepared particles were evaluated for particle size, encapsulation efficiency, drug-polymer interaction by FT-IR and in-vitro drug release. Characterization of microspheres [9] [10] [11] [12] 
Percentage yield
Microspheres dried at room temperature were weighed and the yield of microspheres was calculated using the formula 11, 12 .
( )
Encapsulation Efficiency
To determine encapsulation efficiency, 100mg accurately weighted microspheres were washed and dissolved in 100ml with phosphate buffer pH 7.4 solution. The microspheres were kept to soak for overnight. After 12hrs the solution was filtered through membrane filter. The volume was made up to 100ml with phosphate buffer pH 7.4 and analyzed for drug content spectrophotometrically at 254 nm 13 .
Determination of mean particle size of microspheres
Particle size distribution of microspheres was carried out by optical microscopy. A minute quantity of dried microspheres was suspended in glycerin and the particle size of 100 microspheres was determined in each batch and the mean particle size was calculated. The average particle size was determined by using the Edmondson's equation 9 .
Edmondson's equation D =
Scanning electron microscopy (SEM)
For the external morphology studies, air dried particles were visualized using scanning electron microscopy (FEI-Quanta 
In-vitro release studies
In-vitro release profile for microspheres performed using USP type 1 dissolution apparatus 11, 12 . Sample equivalent to 45mg of nifedipine was added to 900ml phosphate buffer of pH 7.4 at 37±0.5 0 C and stirred at 100rpm. Aliquot of 5ml was withdrawn at time intervals of 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 7, 8, 10 and 12 hrs. The withdrawn volume was replenished with the same volume of dissolution medium in order to keep the total volume constant. The absorbance of the samples was measured at 254nm using phosphate buffer of pH 7.4 as blank. Results of in-vitro drug release studies obtained from absorbance data were tabulated and shown graphically as Cumulative % drug released Vs Time.
Kinetics analysis of dissolution data
There are a number of kinetic models, which described the overall release of drug from the dosage forms 14 . Data obtained from the in-vitro release was fit into different equations and kinetic models to explain the release kinetics of nifedipine from these microspheres. The kinetic models used were a zero-order equation, first order equation, Higuchi and Korsmeyer-Peppas model. Higuchi model is the most widely used model to describe drug release from pharmaceutical matrices system 15 .
The Peppas model is widely used, when the release mechanism is not well known and when more than one type of release is involved. To find out the mechanism of drug release, drug release data were fitted in Korsmeyer-Peppas model 16 . To study the diffusional release mechanism, data obtained from in-vitro drug release studies were plotted against log cumulative percentage drug release versus log time. The value of n was estimated by linear regression of log Mt/M∞ versus log t.
Kt n
Where, is fraction of drug released at time t. t is release time, K is Kinetic constant (incorporating structural and geometric characteristics of preparation), n is Diffusional exponent indicative of the mechanism of the drug release.
RESULTS AND DISCUSSION
Preformulation studies
The solubility of drug in water, 0.1N HCl, 0.1N NaOH, 6.8 pH phosphate buffer, 7.4 pH phosphate buffer were determined and results are shown in Table 2 . The organoleptic properties of nifedipine were performed and physical appearance was good, elegant and results were compiles with pharmacopoeia values of drug characteristics. The melting point of drug was determined and was found to be 172-174 0 C. 
Determination of absorption maximum values
An UV-Spectrophotometric method was used for determination of absorption maxima. The λmax of nifedipine (30μg/ml) in 7.4 pH phosphate buffer was scanned in UV-Visible Spectrophotometer in the wavelength range of 200-400nm and found to have maximum absorbance at 254nm. 
Preparation of standard calibration graph of nifedipine in pH 7.4 phosphate buffer
The solutions of nifedipine were prepared in phosphate buffer pH 7.4 (10-60µg/ml) and the absorbance of resulting solutions was measured at 254nm using UV spectrophotometer. The calibration curve showed a good linearity with correlation coefficient of R 2 0.999. 
Drug and excipients compatibility studies
Fourier Transform Infra-Red Spectroscopy (FT-IR)
FT-IR spectroscopy was used to ensure that no chemical interactions between the drugs and polymer had occurred. The presence of interaction is detected by the disappearance of important functional group of the drug. The FT-IR spectra of nifedipine and polymer mixture showed several characteristic peaks. The FT-IR spectrum of pure nifedipine showed the characteristic peaks at wave numbers of 3320 cm -1 due to >N-H stretching (>N-H of pyridine), at 1680 cm -1 due (N=O)2 asymmetric stretching (Aryl-NO)2, at 1220 cm -1 is due to (N=O)2 symmetric stretching (Aryl-NO2) and at 1520 cm -1 due to asymmetric carboxylate anion confirming the drug structure. The spectrum of nifedipine and polymer mixture also showed the characteristic peaks for nifedipine indicating no interaction between the drug and polymers used. This indicates that there is no chemical interaction between drug and polymer mixture, that the molecular structure of nifedipine remained completely intact. 
Percentage yield
Percentage yield of microspheres is calculated and the percentage yield for all the ratios of microspheres were found to be in the range of 59.25-93.33% and 60.55-94.44% for ethylcellulose and combination of ethylcellulose and hydroxypropyl methylcellulose respectively in which batch MP12 shows highest percentage yield 94.44%. The loss of material during preparation of microspheres may be due to process parameters as well as filtration of microspheres. Percentage yield of all batches is shown in Table 3 .
Encapsulation efficiency
The encapsulation efficiency of all the formulations was found to be in the range of 65.87-94.75% and 70.15-95.23% for formulations composed of ethyl cellulose and combination of ethylcellulose and hydroxypropyl methylcellulose respectively in which batch MP12 shows highest entrapment efficiency 95.23% and batch MP1 shows lowest entrapment efficiency 65.87%. From the results it was seen that as the polymer concentration increased, viscosity of the dispersed phase increased, the encapsulation efficiency increased. This may be because of the availability of high amount of polymer to encapsulate the drug. The values of percentage encapsulation efficiency were shown in Table 3 .
Particle size determination
The mean particle size of microspheres containing ethyl cellulose was found to be 133.5µm, 157.4µm, 189.3µm, 200.5µm, 215.6µm, 223.5µm, 234.7µm, 246.1µm for MP1 to MP8 batches and mean particle size of microspheres containing ethylcellulose and hydroxypropyl methylcellulose combination was found to be 210.1µm, 235.4µm, 243.9µm, 250.6µm for MP9 to MP12 batches respectively. In which MP12 shows highest particle size. As the polymer ratio increased the size of the particles increased. This may be because of viscosity of the polymer solution which increases as the polymer concentration increases and availability of high amount of polymer to coat the drug particles and deposition of many polymer layers.
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Scanning electron microscopy
The microspheres prepared by solvent evaporation method showed a good spherical shape, with smooth surface and the particles are distributed uniformly without any lumps as shown in the Figure 9 . 
In-vitro release studies
The in-vitro release profile of nifedipine microspheres were conducted in pH 7.4 phosphate buffer for 12hrs. The in-vitro drug release data for each of the formulations is shown in Figures 10-12 which has more affinity for water results in increased thermodynamic activity of the drug in the microspheres.
At lower polymer concentration, a burst release was seen, which was more in case of ethyl cellulose and HPMC containing formulations as compared to single ethyl cellulose formulations, which may due to surface drug present on the microspheres. 
Release kinetic plots for best formulation (MP9) microspheres containing nifedipine
The kinetic data of various models revealed that formulations MP1, MP2, MP4, MP6, MP8, MP9, MP11 followed zero order release kinetics with diffusion controlled mechanism and MP3, MP5, MP7, MP10 followed first order release kinetics. The kinetic data of optimized formulation MP9 was shown in the Figures 13-16 . 
CONCLUSION
The present study had been a satisfactory attempt to formulate microspheres of nifedipine, an orally administered calcium channel blocker used in the treatment of angina pectoris drug with a view of improving its oral bioavailability and giving a prolonged release of microspheres with polymers such as ethyl cellulose and hydroxypropyl methylcellulose were successfully prepared by emulsification solvent evaporation method.
Based on the results obtained it can be concluded that MP9 was found to be the ideal formulation considering its size and release profile. Hence microspheres were better choice of drug delivery system than many other types of drug delivery system and plays vital role in place in novel drug delivery, particularly in diseased cell sorting, diagnostics, gene and genetic materials, safe, targeted, specific drug delivery. 
